Centenial Surgical Suture Ltd. (CSURGSU.BO)
BSE · INR · Healthcare · Medical Instruments & Supplies
₹71.25 (+0.00%) as of
Key statistics
- Market cap
- 259.94M
- EPS (TTM)
- -3.96
- Dividend yield
- 0.00%
- 52-week range
- 66.60 – 124.90
- Beta
- 0.20
- Revenue (TTM)
- 562.47M
- Profit margin
- -2.54%
- Volume
- 142.00
About Centenial Surgical Suture Ltd.
Centenial Surgical Suture Ltd., a medical device company, engages in the manufacture and sale of surgical sutures and other medical devices in India and internationally. It provides absorbable sutures, such as catgut, centicryl, centicryl rapid, centisorb, centisorb rapid, centisorb tri-plus, centisynth, and monosynth; non-absorbable sutures, including centibond, centidene, centisilk, centlon, and centsteel; and superior atraumatic needle products. The company also provides cardiovascular sutures; and other medical devices that comprise centipunch, centcel, centiitape, centiiwax, centilene mesh, centipace, and centipled, as well as disposable surgical skin stapler; and biomaterials. Centenial Surgical Suture Ltd. was incorporated in 1995 and is based in Thane, India.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Headquarters
- Thane, India
- Employees
- 266
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.